| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.74B | 50.31B | 50.45B | 46.52B | 59.82B | 54.11B |
| Gross Profit | 5.08B | 5.52B | 4.99B | 4.67B | 5.80B | 5.08B |
| EBITDA | 5.30B | 5.32B | 5.27B | 4.73B | 5.66B | 4.92B |
| Net Income | 2.26B | 2.54B | 2.19B | 2.05B | 2.70B | 2.26B |
Balance Sheet | ||||||
| Total Assets | 51.13B | 59.77B | 51.11B | 49.50B | 44.44B | 41.99B |
| Cash, Cash Equivalents and Short-Term Investments | 9.71B | 4.86B | 9.46B | 9.42B | 9.31B | 7.10B |
| Total Debt | 8.26B | 12.23B | 8.58B | 9.10B | 9.66B | 10.42B |
| Total Liabilities | 20.67B | 25.97B | 20.84B | 21.26B | 19.98B | 20.49B |
| Stockholders Equity | 30.45B | 33.79B | 30.26B | 28.23B | 24.46B | 21.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.16B | 1.12B | 1.41B | 3.36B | 3.52B |
| Operating Cash Flow | 0.00 | 5.63B | 3.80B | 3.91B | 5.24B | 4.52B |
| Investing Cash Flow | 0.00 | -12.11B | -2.83B | -2.67B | -2.01B | -784.00M |
| Financing Cash Flow | 0.00 | 2.72B | -1.26B | -1.38B | -1.23B | -2.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥144.51B | 10.77 | ― | 3.65% | 3.06% | 1.48% | |
69 Neutral | ¥18.73B | 7.10 | ― | 2.46% | -0.28% | 15.95% | |
67 Neutral | ¥70.88B | 11.67 | ― | 3.63% | 0.60% | 10.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥307.18B | 26.94 | ― | 1.28% | 6.67% | 10.43% | |
59 Neutral | ¥334.63B | 18.56 | 8.30% | 2.50% | 5.27% | -5.79% | |
59 Neutral | ¥297.34B | 17.48 | ― | 2.94% | 1.47% | -10.54% |